Drug Discovery and Development
Drug Discovery and DevelopmentPublished 1 January 1987
Michael Williams, Jeffrey B. Malick
Citations29
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
The process of drug discovery involves a melding of many disciplines and interests, transcending the relatively simple process of identifying an active compound in the test tube. The discovery of a novel chemical entity that modulates some aspect of cell or tissue function is but the first step in the drug development process. Once shown to be selective and efficacious, a compound must also be relatively free of toxicity, bioavailable, and marketable before it can be considered to be a therapeutic entity.
Keywords
Computer ScienceMedicinePharmacology, Toxicology and Pharmaceutics
ScienceChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
4,887 Citations1983J. William Langston, Philip L. Ballard +2 more
It is proposed that this chemical selectively damages cells in the substantia nigra in patients who developed marked parkinsonism after using an illicit drug intravenously.
NatureDefinition and Antagonism of Histamine H2-receptors
2,280 Citations1972J. W. Black, W. A. M. Duncan +3 more
H2-receptor antagonist, a new group of drugs, may help to unravel the physiology of histamine and gastrin.
Foreign AffairsThe Culture of Narcissism: American Life in an Age of Diminishing Expectations
1,601 Citations1979Gaddis Smith, Christopher Lasch
NatureBenzodiazepine receptors in rat brain
1,453 Citations1977Richard F. Squires, Claus Bræstrup
Experiments suggest that another important group of psychoactive drugs, the benzodiazepines, bind to specific receptors on the membranes of rat brain cells, and this suggests that there may be an unknown endogenous neurotransmitter which is the natural ligand for the Benzodiazepine receptor.
ScienceIvermectin: A Potent New Antiparasitic Agent
828 Citations1983William C. Campbell, M. H. FISHER +3 more
Ivermectin is the 22,23-dihydro derivative of avermECTin B1, a macrocyclic lactone produced by an actinomycete, Streptomyces avermitilis, in commercial use in various countries for the treatment and control of parasites in cattle, horses, and sheep, and is expected to become available for use in swine and dogs.
Brain Research ReviewsAcidic amino acid binding sites in mammalian neuronal membranes: their characteristics and relationship to synaptic receptors
822 Citations1984Alan C. Foster, Graham E. Fagg
An evaluation of investigations designed to elucidate regulatory mechanisms at acidic amino acid binding sites is made; hypotheses such as the Ca2+-activated protease hypothesis of long-term potentiation are assessed in terms of the new binding site/receptor classification scheme.
NatureA new class of angiotensin-converting enzyme inhibitors
706 Citations1980Arthur A. Patchett, Elbert E. Harris +25 more
This work reports on the design of a novel series of substituted N-carboxymethyl-dipeptides which are active in inhibiting angiotensin-converting enzyme at nanomolar levels and suggests that these compounds are transition-state inhibitors.
Archives of General PsychiatryReceptor Sensitivity and the Mechanism of Action of Antidepressant Treatment
648 Citations1981Dennis S. Charney
The effects of long-term antidepressant treatment on biogenic amine metabolism and on various indexes of presynaptic and postsynaptic receptor function are evaluated to provide support for hypotheses of amine receptor abnormalities in depression and indicate the need for expanded studies ofAmine receptor function in patients.
Drug Development ResearchAnticonvulsant activity of (+)‐5‐methyl‐10, 11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
498 Citations1982Bradley V. Clineschmidt, Gregory E. Martin +1 more
Besides being a potent anticonvulsant, MK‐801 demonstrated selectivity, since much higher doses were required in mice to block clonic convulsions produced by pentylenetetrazol and tonic seizures caused by strychnine than were needed against electroshock or bicuculline.
Archives of General PsychiatryAntischizophrenic Drugs and Brain Cholinergic Receptors
475 Citations1974Solomon H. Snyder
The influence of a variety of antisch schizophrenic drugs on the brain's receptor for the muscarinic action of acetylcholine is reported to provide a means to predict extrapyramidal actions of new potential antischizophrenic drugs.
Proceedings of the National Academy of SciencesProperties of Opiate-Receptor Binding in Rat Brain
439 Citations1973Candace B. Pert, Solomon H. Snyder
Potencies of opiates and their antagonists in displacing [(3)H]naloxone binding parallel their pharmacological potencies.
European Journal of PharmacologySpecific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine binding
249 Citations1980Rita Raisman, Michael S. Briley +1 more
It is concluded that these 3H-imipramine binding sites may be important in the study of depression and of the mechanism of action of antidepressant drugs.
Journal of Medicinal Chemistry2-Arylpyrazolo[4,3-c]quinolin-3-ones: a novel agonist, a partial agonist and an antagonist of benzodiazepines
215 Citations1982Naokata Yokoyama, Barry Ritter +1 more
Journal of Medicinal ChemistryComputer-assisted drug design
210 Citations1985A. J. Hopfinger
Evolution dans le domaine de la conception assistee par ordinateur de medicaments au cours des quatre dernieres annees est toujours difficile.
Biochemical PharmacologyInhibition of dopa decarboxylase by the hydrazino analog of α-methyldopa
166 Citations1962C. C. Porter, Lauren Watson +3 more
Dl -σ-Methyl-α-hydrazino-3,4-dihydroxyphenylpropionic acid (HMD) is a potent inhibitor of DOPA decarboxylase in vitro and apparently did not inhibit monoamine oxidase in vivo.
Proceedings of the National Academy of SciencesAutoradiographic visualization of angiotensin-converting enzyme in rat brain with [3H]captopril: localization to a striatonigral pathway.
146 Citations1984Stephen M. Strittmatter, Mathew M. S. Lo +2 more
Although in vitro [3H]captopril autoradiography reveals ACE in a striatonigral pathway, there is no evidence for angiotensin II involvement in such a neuronal pathway.
Biochemical PharmacologyCriteria for receptor sites in binding studies
129 Citations1984Pierre M. Laduron
The tendency to interpret anomalous or intriguing results in terms of new receptor subtypes seems to have reached its peak and the need to apply severe criteria becomes imperative before concluding that a binding site may be called a receptor site.
Journal of the American Chemical SocietyThe absolute stereochemistry and conformation of avermectin B2a aglycone and avermectin B1a
104 Citations1981James P. Springer, Byron H. Arison +2 more
Journal of Medicinal ChemistryDrug design by the method of receptor fit
99 Citations1984P. J. Goodford
Molecular PharmacologyAnomalous Properties of [3H]Spiperone Binding Sites in Various Areas of the Rat Limbic System
92 Citations1979David Howlett, Helen Morris +1 more
These [3H]spiperone binding sites show strict structure-affinity relationships in that only spirodecanone butyrophenone derivatives and dopamine are capable of displacing this binding with relatively high affinities, emphasize the complex nature of neuroleptic/dopamine "receptor" binding sites in brain and the need for precise definition of such "specific" binding Sites.
ScienceSolubilized Adenosine Receptors in the Brain: Regulation of Guanine Nucleotides
89 Citations1982Moshe Gavish, Robert Goodman +1 more
The apparent retention of a complex of receptors and guanosine triphosphate binding but not cation binding protein in the soluble state may permit a molecular analysis of receptor regulation.
Biochemical PharmacologyNeurotransmitter and drug receptors in the brain
71 Citations1975Solomon H. Snyder
Journal of Medicinal ChemistryImproved delivery through biological membranes. 13. Brain-specific delivery of dopamine with a dihydropyridine .dblharw. pyridinium salt type redox delivery system
61 Citations1983Nicholas Bodor, Hassan H. Farag
The dihydropyridine in equilibrium with pyridinium salt type redox delivery system was used for the brain-specific delivery of dopamine, which locked in the brain for many hours, while systemic concentration decreased fast, with a t 1/2 of less than 30 min.
Journal of Biological Chemistry[3H]guanidinoethylmercaptosuccinic acid binding to tissue homogenates. Selective labeling of enkephalin convertase.
43 Citations1984Stephen M. Strittmatter, David R. Lynch +1 more
Data confirm that [3H]GEMSA binds only to enkephalin convertase in crude homogenates under the authors' assay conditions.
Journal of Medicinal ChemistryNeurotransmitter receptor binding and drug discovery
22 Citations1983Solomon H. Snyder
New England Journal of MedicinePump Blockers and Ulcer Disease
22 Citations1984George Sachs
Treatment of ulcer disease has focused largely on the control of luminal acidity, even though methods of altering the response of a lesion to acidity are also being explored.
Drug Development ResearchThe state of the art of the science of drug discovery—an opinion
19 Citations1984R.A. Maxwell
A more reasonable model of the relationship between drug discovery (and development) and nonindustrial research—physiological, biochemical, and pharmacological—is that of symbiosis with each segment nurturing the other to mutual benefit.
ScienceBiotechnology in Pharmaceuticals: The Japanese Challenge
17 Citations1985Mark D. Dibner
Strategies used by the United States and Japan to incorporate biotechnology into their pharmaceutical industries are examined and compared.
Annual reports in medicinal chemistryChapter 21: The Receptor: From Concept to Function
14 Citations1986Michael Williams, S.J. Enna
The chapter describes receptor theory, provides cooperative models of receptor action—the concerted model and sequential model, and reviews receptor antagonists and receptor localization.
Journal of Pharmacology and Experimental TherapeuticsStereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadine.
12 Citations1979Bradley V. Clineschmidt, M A McKendry +5 more
The ratios of (+-CTC and (-)-CTC in terms of their anti-alpha adrenergic/antidopaminergic properties were large, suggesting a low propensity for the elicitation of orthostatic hypotension and sedation.
Annual reports in medicinal chemistryChapter 28. Drug Discovery at the Molecular Level: A Decade of Radioligand Binding in Retrospect
7 Citations1984Michael Williams, David C. U’Prichard
Ligand binding methods have facilitated the study of receptor alterations in disease states, whether secondary or presumptively etiological, examples include human postmortem brain tissue obtained from patients with neurodegenerative or psychiatric (schizophrenia) disorders and in formed blood elements obtained before or during drug treatment.
Drug Development ResearchBiochemical characterization of the enantiomers of the novel ergoline dopamine agonist 6‐ethyl‐9‐oxaergoline (EOE)
6 Citations1983Michael Williams, James H. Jones +1 more
Examination of EOE in the DA‐sensitive adenylate cyclase system of carp retina showed that while the (−)enantiomer was a partial agonist some 30 times less active than dopamine, the (+)enaliomer was devoid of activity in this D‐1 coupled system at concentrations up to 300 μM.
Trends in Pharmacological SciencesThe pharmaceutical industry: impacts of biotechnology
6 Citations1985Mark D. Dibner
Excitatory Amino Acid Receptors
6 Citations1984Najam A. Sharif
Specific synaptic binding proteins and receptor-mediated ionic fluxes and cyclic nucleotide generation associated with Glu and Asp have been detected and extensively evaluated and release of endogenous and exogenous AAs from CNS preparations by depolarizing stimuli has been demonstrated.
Chemical & Engineering NewsCareer Opportunities for Chemical Professionals
3 Citations1985Michael K. Badawy
Journal of Pharmacology and Experimental TherapeuticsL-646,462, a cyproheptadine-related antagonist of dopamine and serotonin with selectivity for peripheral systems.
3 Citations1984Michael Williams, G.E. Martin +8 more
L-646,462 is selective in vivo, preferentially blocking dopamine and 5-HT receptors located outside the blood-brain barrier, while being less potent and less selective than metoclopramide and domperidone.
